Skip to content
Endpoint Health logo

Endpoint Health

Endpoint Health is a YC Winter 2019 (W19) company. Based in Palo Alto, CA, USA; Remote. Team of 23.

About Endpoint Health

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Endpoint Health develops precision therapeutics and companion diagnostic tests for immune-driven critical and chronic diseases. It targets patients whose biology makes standard treatments ineffective, replacing one-size-fits-all prescribing with matched therapy selection. The company builds both the drugs and the tests needed to identify which patients will respond to them.

From the Y Combinator listing

How Endpoint Health describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Precision-first therapies

Endpoint Health is on a mission to address urgent needs in immune-driven critical and chronic illnesses by delivering therapies that are personalized to each patient’s biology. We built Endpoint Health from the ground up to develop and commercialize therapeutics and therapy-guiding tests, to ensure that every patient receives personalized treatment that will dramatically improve their outcomes. Our vision is a world in which all patients have effective, personalized treatment, because therapies are targeted to the right patient at the right time.

Facts

Industry
Healthcare / Healthcare -> Therapeutics
Location
Palo Alto, CA, USA; Remote
Team size
23
Status
Active
Stage
Growth

Founders (4)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works